These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 30184728)

  • 1. Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics.
    Ding D; Zhu Q
    Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():1041-1060. PubMed ID: 30184728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of Biodegradable PLGA-Nanoparticles Used for pH-Sensitive Intracellular Delivery of an Anti-inflammatory Bacterial Toxin to Macrophages.
    Harada A; Tsutsuki H; Zhang T; Lee R; Yahiro K; Sawa T; Niidome T
    Chem Pharm Bull (Tokyo); 2020; 68(4):363-368. PubMed ID: 32238653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent applications of PLGA based nanostructures in drug delivery.
    Mir M; Ahmed N; Rehman AU
    Colloids Surf B Biointerfaces; 2017 Nov; 159():217-231. PubMed ID: 28797972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microfluidics for producing poly (lactic-co-glycolic acid)-based pharmaceutical nanoparticles.
    Li X; Jiang X
    Adv Drug Deliv Rev; 2018 Mar; 128():101-114. PubMed ID: 29277543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Customizing poly(lactic-co-glycolic acid) particles for biomedical applications.
    Swider E; Koshkina O; Tel J; Cruz LJ; de Vries IJM; Srinivas M
    Acta Biomater; 2018 Jun; 73():38-51. PubMed ID: 29653217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application.
    Su Y; Zhang B; Sun R; Liu W; Zhu Q; Zhang X; Wang R; Chen C
    Drug Deliv; 2021 Dec; 28(1):1397-1418. PubMed ID: 34184949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational design of Phe-Tyr dipeptide and preparation, characterization, cytotoxicity studies of Phe-Tyr dipeptide loaded PLGA nanoparticles for the treatment of hypertension.
    Kecel-Gündüz S; Budama-Kilinc Y; Cakir Koc R; Kökcü Y; Bicak B; Aslan B; Özel AE
    J Biomol Struct Dyn; 2018 Aug; 36(11):2893-2907. PubMed ID: 28835169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cover Story Enhanced intrapericardial drug delivery by PLGA nanoparticles.
    Park K
    J Control Release; 2017 Sep; 262():357. PubMed ID: 28919045
    [No Abstract]   [Full Text] [Related]  

  • 9. Translating the fabrication of protein-loaded poly(lactic-co-glycolic acid) nanoparticles from bench to scale-independent production using microfluidics.
    Roces CB; Christensen D; Perrie Y
    Drug Deliv Transl Res; 2020 Jun; 10(3):582-593. PubMed ID: 31919746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploiting PLGA-Based Biocompatible Nanoparticles for Next-Generation Tolerogenic Vaccines against Autoimmune Disease.
    Cappellano G; Comi C; Chiocchetti A; Dianzani U
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30626016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(d,l-lactide-co-glycolide) Nanoparticles as Delivery Platforms for TLR7/8 Agonist-Based Cancer Vaccine.
    Kim H; Griffith TS; Panyam J
    J Pharmacol Exp Ther; 2019 Sep; 370(3):715-724. PubMed ID: 30610006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxcarbazepine free or loaded PLGA nanoparticles as effective intranasal approach to control epileptic seizures in rodents.
    Musumeci T; Serapide MF; Pellitteri R; Dalpiaz A; Ferraro L; Dal Magro R; Bonaccorso A; Carbone C; Veiga F; Sancini G; Puglisi G
    Eur J Pharm Biopharm; 2018 Dec; 133():309-320. PubMed ID: 30399400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PLGA-Based Composites for Various Biomedical Applications.
    Rocha CV; Gonçalves V; da Silva MC; Bañobre-López M; Gallo J
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered PLGA nanoparticles: an emerging delivery tool in cancer therapeutics.
    Jain AK; Das M; Swarnakar NK; Jain S
    Crit Rev Ther Drug Carrier Syst; 2011; 28(1):1-45. PubMed ID: 21395514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
    Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
    Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aptamer-conjugated PLGA nanoparticles for delivery and imaging of cancer therapeutic drugs.
    Hashemi M; Shamshiri A; Saeedi M; Tayebi L; Yazdian-Robati R
    Arch Biochem Biophys; 2020 Sep; 691():108485. PubMed ID: 32712288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH-responsive Astragalus polysaccharides-loaded poly(lactic-co-glycolic acid) nanoparticles and their in vitro immunogenicity.
    Xu S; Wusiman A; Liu Z; Gu P; Ni H; Zhang Y; Hu Y; Liu J; Wu Y; Wang D
    Int J Biol Macromol; 2019 Mar; 125():865-875. PubMed ID: 30576729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and characterization of poly(propylacrylic acid)/poly(lactic-co-glycolic acid) blend microparticles for pH-dependent membrane disruption and cytosolic delivery.
    Fernando LP; Lewis JS; Evans BC; Duvall CL; Keselowsky BG
    J Biomed Mater Res A; 2018 Apr; 106(4):1022-1033. PubMed ID: 29164777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(lactic-co-glycolic) Acid (PLGA) Nanoparticles and Transdermal Drug Delivery: An Overview.
    Kumar L; Kukreti G; Rana R; Chaurasia H; Sharma A; Sharma N; Komal
    Curr Pharm Des; 2023; 29(37):2940-2953. PubMed ID: 38173050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid β aggregation in Alzheimer's disease.
    Huo X; Zhang Y; Jin X; Li Y; Zhang L
    J Photochem Photobiol B; 2019 Jan; 190():98-102. PubMed ID: 30504054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.